Zhuzhou Qianjin Pharmaceutical Hits Day Low Amid Price Pressure at CNY 9.86

Zhuzhou Qianjin Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 7.54% and reaching an intraday low of CNY 9.86. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% during the same period. Over the past week, Zhuzhou Qianjin has seen a decrease of 9.65%, while its monthly performance reflects a decline of 9.81%. Year-to-date, the stock is down 2.26%, underperforming the market, which has seen a slight decline of 3.92%. In the last year, the stock has generated a return of 8.60%, significantly lower than the China Shanghai Composite's return of 22.49%. Financial metrics indicate that the company has faced challenges, with net sales growing at an annual rate of only 0.04% and operating profit at 1.79% over the past five years. The company's market capitalization stands at CNY 4,608 million, and it has a P/E ratio of 13.00. Despite a dividend yield of 3.36%, the stock's performance has raised concerns among market observers.